PT  - JOURNAL ARTICLE
AU  - Blauwendraat, Cornelis
AU  - Iwaki, Hirotaka
AU  - Makarious, Mary B.
AU  - Bandres-Ciga, Sara
AU  - Leonard, Hampton
AU  - Grenn, Francis P.
AU  - Lake, Julie
AU  - Krohn, Lynne
AU  - Tan, Manuela
AU  - Kim, Jonggeol Jeff
AU  - Gibbs, Jesse Raphael
AU  - Hernandez, Dena G.
AU  - Ruskey, Jennifer A.
AU  - Pihlstrøm, Lasse
AU  - Toft, Mathias
AU  - van Hilten, Jacobus J.
AU  - Marinus, Johan
AU  - Schulte, Claudia
AU  - Brockmann, Kathrin
AU  - Sharma, Manu
AU  - Siitonen, Ari
AU  - Majamaa, Kari
AU  - Eerola-Rautio, Johanna
AU  - Tienari, Pentti J.
AU  - Grosset, Donald
AU  - Lesage, Suzanne
AU  - Corvol, Jean-Christophe
AU  - Brice, Alexis
AU  - Wood, Nick
AU  - Hardy, John
AU  - Gan-Or, Ziv
AU  - Heutink, Peter
AU  - Gasser, Thomas
AU  - Morris, Huw
AU  - Noyce, Alastair J.
AU  - Nalls, Mike A.
AU  - Singleton, Andrew B.
AU  - ,
TI  - Investigation of Autosomal Genetic Sex Differences in Parkinson’s disease
AID  - 10.1101/2021.02.09.21250262
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.02.09.21250262
4099  - http://medrxiv.org/content/early/2021/02/12/2021.02.09.21250262.short
4100  - http://medrxiv.org/content/early/2021/02/12/2021.02.09.21250262.full
AB  - Parkinson’s disease (PD) is a complex neurodegenerative disorder. Males are on average ∼1.5 times more likely to develop PD compared to females. Over the years genome-wide association studies (GWAS) have identified numerous genetic risk factors for PD, however it is unclear whether genetics contribute to disease etiology in a sex-specific manner.In an effort to study sex-specific genetic factors associated with PD, we explored two large genetic datasets from the International Parkinson’s Disease Genomics Consortium and the UK Biobank consisting of 13,020 male PD cases, 7,936 paternal proxy cases, 89,660 male controls, 7,947 female PD cases, 5,473 maternal proxy cases and 90,662 female controls. We performed GWAS meta-analyses to identify distinct patterns of genetic risk contributing to disease in male versus female PD cases.In total 19 genome-wide significant regions were identified, and no sex-specific effects were observed. A high genetic correlation between the male and female PD GWASes was identified (rg=0.877) and heritability estimates were identical between male and female PD cases (∼20%).We did not detect any significant genetic differences between male or female PD cases. Our study does not support the notion that common genetic variation on the autosomes could explain the difference in prevalence of PD between males and females at least when considering the current sample size under study. Further studies are warranted to investigate the genetic architecture of PD explained by X and Y chromosomes and further evaluate environmental effects that could potentially contribute to PD etiology in male versus females.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported in part by the Intramural Research Programs of the National Institute on Aging (NIA)Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Participants clinical information and genetic samples were obtained with appropriate written consent and local institutional and ethical approval. All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived. Additionally, our project is covered by all relevant, local IRBs from which the data were derived. All data were de-identified prior to sharing with researchers, and therefore, researchers did not have access to any information on the included subjects. As a result, our study design was reviewed by the NIH Office of IRB Operations, and the reviewing body determined that the research activities did not require IRB approval or review. UK Biobank data were obtained under the application number 33601.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll summary statistics are available at https://pdgenetics.org/resources. Six summary statistics tables are made available: 1) Male PD GWAS (all data), 2) Female PD GWAS (all data), 3) Male PD GWAS (no UKB proxy data), 4) Female PD GWAS (no UKB proxy data), 5) Male PD GWAS (no UKB data) and 6) Female PD GWAS (no UKB data). All code used has been made available on GitHub: https://github.com/neurogenetics/Autosomal-sex-differences-PDv2. https://pdgenetics.org/resources https://github.com/neurogenetics/Autosomal-sex-differences-PDv2